Effect of vaginal immunization with HIVgp140 and HSP70 on HIV-1 replication and innate and T cell adaptive immunity in women

Journal of Virology

Volumn 88, Issue 20, 2014, Pages 11648-11657

  Lewis, David J M ^a   Wang, Yufei ^b   Huo, Zhiming ^a   Giemza, Raphaela ^c   Babaahmady, Kaboutar ^d   Rahman, Durdana ^b   Shattock, Robin J ^d   Singh, Mahavir ^e   Lehner, Thomas ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e LIONEX DIAGNOSTICS AND THERAPEUTICS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CN54GP140 GLYCOPROTEIN HSP70 CONJUGATE VACCINE; GAMMA INTERFERON; GLYCOPROTEIN GP 140; HEAT SHOCK PROTEIN 70; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PLACEBO; RANTES; UNCLASSIFIED DRUG; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADAPTIVE IMMUNITY; ADULT; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DRUG SAFETY; ERYTHEMA; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS 1; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; NEW ZEALAND WHITE (RABBIT); NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE 1 CLINICAL TRIAL; UPREGULATION; UTERINE CERVIX MUCUS; VAGINA DISCHARGE; VAGINAL SECRETION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; VULVA DISEASE; VULVAL ERYTHEMA; VULVITIS; ANIMAL; BIOSYNTHESIS; IMMUNOLOGY; PATHOGENICITY; PHYSIOLOGY; RABBIT; T LYMPHOCYTE; VAGINA; YOUNG ADULT;

ADULT; AIDS VACCINES; ANIMALS; FEMALE; HIV ENVELOPE PROTEIN GP41; HIV-1; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RABBITS; T-LYMPHOCYTES; VAGINA; VIRUS REPLICATION; YOUNG ADULT;

EID: 84907907838     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01621-14     Document Type: Article

References (43)

1. McMichael A, Picker LJ, Moore JP, Burton DR. 2013. Another HIV vaccine failure: where to next? Nat. Med. 19:1576-1577. http://dx.doi.org /10.1038/nm.3413.
2. Gray G, Buchbinder S, Duerr A. 2010. Overview of STEP and Phambili trial results:twophase IIb test-of-concept studies investigating the efficacy ofMRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine. Curr. Opin. HIV AIDS 5:357-361. http://dx.doi.org/10.1097/COH.0b013e32833d2d2b.
3. Haynes BF, McElrath MJ. 2013. Progress in HIV-1 vaccine development. Curr. Opin. HIV AIDS 8:326-332. http://dx.doi.org/10.1097/COH.0b013e328361d178.
4. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, Hanifin JM, Slifka MK. 2003. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9:1131-1137. http://dx.doi.org/10.1038 /nm917.
5. Gaucher D, Therrien R, Kettaf N, Angermann BR, Boucher G, Filali-Mouhim A, Moser JM, Mehta RS, Drake DR, III, Castro E, Akondy R, Rinfret A, Yassine-Diab B, Said EA, Chouikh Y, Cameron MJ, Clum R, Kelvin D, Somogyi R, Greller LD, Balderas RS, Wilkinson P, Pantaleo G, Tartaglia J, Haddad EK, Sekaly RP. 2008. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205:3119-3131. http://dx.doi.org/10.1084/jem.20082292.
6. Sheehy AM, Gaddis NC, Choi JD, Malim MH. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650. http://dx.doi.org/10.1038/nature00939.
7. Pido-Lopez J, Whittall T, Wang Y, Bergmeier LA, Babaahmady K, Singh M, Lehner T. 2007. Stimulation of cell surface CCR5 and CD40 molecules by their ligands or by HSP70 up-regulates APOBEC3G expression in CD4(+) T cells and dendritic cells. J. Immunol. 178:1671-1679. http://dx.doi.org/10.4049/jimmunol.178.3.1671.
8. Wang Y, Bergmeier LA, Stebbings R, Seidl T, Whittall T, Singh M, Berry N, Almond N, Lehner T. 2009. Mucosal immunization in macaques upregulates the innate APOBEC 3G anti-viral factor in CD4(+) memory T cells. Vaccine 27:870-881. http://dx.doi.org/10.1016/j.vaccine.2008.11.084.
9. Sugiyama R, Nishitsuji H, Furukawa A, Katahira M, Habu Y, Takeuchi H, Ryo A, Takaku H. 2011. Heat shock protein 70 inhibits HIV-1 Vifmediated ubiquitination and degradation of APOBEC3G. J. Biol. Chem. 286:10051-10057. http://dx.doi.org/10.1074/jbc.M110.166108.
10. Su L, Graf M, Zhang Y, von Briesen H, Xing H, Kostler J, Melzl H, Wolf H, Shao Y, Wagner R. 2000. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J. Virol. 74:11367-11376. http: //dx.doi.org/10.1128/JVI.74.23.11367-11376.2000.
11. Srivastava P. 2002. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2:185-194. http://dx.doi.org/10.1038 /nri749.
12. Panjwani N, Akbari O, Garcia S, Brazil M, Stockinger B. 1999. The HSC73 molecular chaperone: involvement in MHC class II antigen presentation. J. Immunol. 163:1936-1942.
13. Castellino F, Boucher PE, Eichelberg K, Mayhew M, Rothman JE, Houghton AN, Germain RN. 2000. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J. Exp. Med. 191:1957-1964. http://dx.doi.org/10.1084/jem.191.11.1957.
14. Wang Y, Kelly CG, Karttunen JT, Whittall T, Lehner PJ, Duncan L, MacAry P, Younson JS, Singh M, Oehlmann W, Cheng G, Bergmeier L, Lehner T. 2001. CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 15:971-983. http://dx.doi.org/10.1016/S1074-7613(01)00242-4.
15. Wang Y, Kelly CG, Singh M, McGowan EG, Carrara AS, Bergmeier LA, Lehner T. 2002. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J. Immunol. 169:2422-2429. http://dx.doi.org/10.4049/jimmunol.169.5.2422.
16. Pido-Lopez J, Wang Y, Seidl T, Babaahmady K, Vaughan R, Lehner T. 2009. The effect of allogeneic in vitro stimulation and in vivo immunization on memory CD4(+) T-cell APOBEC3G expression and HIV-1 infectivity. Eur. J. Immunol. 39:1956-1965. http://dx.doi.org/10.1002/eji.200939228.
17. Becker T, Hartl FU, Wieland F. 2002. CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell Biol. 158:1277-1285. http://dx.doi.org/10.1083/jcb.200208083.
18. Floto RA, MacAry PA, Boname JM, Mien TS, Kampmann B, Hair JR, Huey OS, Houben EN, Pieters J, Day C, Oehlmann W, Singh M, Smith KG, Lehner PJ. 2006. Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5. Science 314:454-458. http://dx.doi.org/10.1126/science.1133515.
19. Whittall T, Wang Y, Younson J, Kelly C, Bergmeier L, Peters B, Singh M, Lehner T. 2006. Interaction between the CCR5 chemokine receptors and microbial HSP70. Eur. J. Immunol. 36:2304-2314. http://dx.doi.org /10.1002/eji.200635953.
20. Babaahmady K, Oehlmann W, Singh M, Lehner T. 2007. Inhibition of human immunodeficiency virus type 1 infection of human CD4+ T cells by microbial HSP70 and the peptide epitope 407-426. J. Virol. 81:3354-3360. http://dx.doi.org/10.1128/JVI.02320-06.
21. Bogers WM, Bergmeier LA, Ma J, Oostermeijer H, Wang Y, Kelly CG, Ten Haaft P, Singh M, Heeney JL, Lehner T. 2004. A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection. AIDS 18:25-36. http://dx.doi.org/10.1097/00002030-200401020-00003.
22. Barrios C, Georgopoulos C, Lambert PH, Del Giudice G. 1994. Heat shock proteins as carrier molecules: in vivo helper effect mediated by Escherichia coli GroEL and DnaK proteins requires cross-linking with antigen. Clin. Exp. Immunol. 98:229-233.
23. Curran RM, Donnelly L, Morrow RJ, Fraser C, Andrews G, Cranage M, Malcolm RK, Shattock RJ, Woolfson AD. 2009. Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune re-sponses. Vaccine 27:6791-6798. http://dx.doi.org/10.1016/j.vaccine.2009.08.088.
24. Lewis DJ, Fraser CA, Mahmoud AN, Wiggins RC, Woodrow M, Cope A, Cai C, Giemza R, Jeffs SA, Manoussaka M, Cole T, Cranage MP, Shattock RJ, Lacey CJ. 2011. Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally. PLoS One 6:e25165. http://dx.doi.org/10.1371/journal.pone.0025165.
25. Kingsley C, Peters B, Babaahmady K, Pomeroy L, Rahman D, Vaughan R, Lehner T. 2009. Heterosexual and homosexual partners practising unprotected sex may develop allogeneic immunity and to a lesser extent tolerance. PLoS One 4:e7938. http://dx.doi.org/10.1371/journal.pone.0007938.
26. Hoebe K, Janssen E, Beutler B. 2004. The interface between innate and adaptive immunity. Nat. Immunol. 5:971-974. http://dx.doi.org/10.1038 /ni1004-971.
27. Lehner T, Bergmeier LA, Panagiotidi C, Tao L, Brookes R, Klavinskis LS, Walker P, Walker J, Ward RG, Hussain L. 1992. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258:1365-1369. http://dx.doi.org/10.1126 /science.1360702.
28. Klavinskis LS, Bergmeier LA, Gao L, Mitchell E, Ward RG, Layton G, Brookes R, Meyers NJ, Lehner T. 1996. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virusspecific CTL in the genito-rectal mucosa and draining lymph nodes. J. Immunol. 157:2521-2527.
29. Wang Y, Abel K, Lantz K, Krieg AM, McChesney MB, Miller CJ. 2005. The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J. Virol. 79:14355-14370. http: //dx.doi.org/10.1128/JVI.79.22.14355-14370.2005.
30. Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, Cu-Uvin S, Neutra MR. 2002. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J. Immunol. 169:566-574. http://dx.doi.org/10.4049/jimmunol.169.1.566.
31. Stephenson KE, Li H, Walker BD, Michael NL, Barouch DH. 2012. Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys. J. Virol. 86:9583-9589. http://dx.doi.org/10.1128/JVI.00996-12.
32. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. 1996. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958. http://dx.doi.org/10.1126/science.272.5270.1955.
33. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666. http://dx.doi.org/10.1038/381661a0.
34. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA. 1996. HIV-1 entry into CD4+cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673. http://dx.doi.org/10.1038/381667a0.
35. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811-1815. http://dx.doi.org/10.1126/science.270.5243.1811.
36. Wang Y, Tao L, Mitchell E, Bravery C, Berlingieri P, Armstrong P, Vaughan R, Underwood J, Lehner T. 1999. Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women. Nat. Med. 5:1004-1009. http://dx.doi.org/10.1038/12440.
37. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, Koup RA. 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med. 2:412-417. http://dx.doi.org/10.1038/nm0496-412.
38. Lehner T, Bergmeier LA, Wang Y, Tao L, Sing M, Spallek R, van der Zee R. 2000. Heat shock proteins generate beta-chemokines which function as innate adjuvants enhancing adaptive immunity. Eur. J. Immunol. 30:594-603. http://dx.doi.org/10.1002/1521-4141(200002) 30:2594::AID-IMMU594 3.0.CO;2-1.
39. Lehner T, Tao L, Panagiotidi C, Klavinskis LS, Brookes R, Hussain L, Meyers N, Adams SE, Gearing AJ, Bergmeier LA. 1994. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J. Virol. 68:1624-1632.
40. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN, Step Study Protocol Team. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372:1881-1893. http://dx.doi.org/10.1016/S0140-6736(08)61591-3.
41. Wang Y, Tao L, Mitchell E, Bergmeier L, Doyle C, Lehner T. 1999. The effect of immunization on chemokines and CCR5 and CXCR4 coreceptor functions in SIV binding and chemotaxis. Vaccine 17:1826-1836. http: //dx.doi.org/10.1016/S0264-410X(98)00482-4.
42. O'Leary JGM, Goofdarzi M, Drayton DL, von Andrian UH. 2006. T celland B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 5:507-516. http://dx.doi.org/10.1038/ni1332.
43. Pulendran B, Ahmed R. 2006. Translating innate immunity into immunological memory: implications for vaccine development. Cell 124:849-863. http://dx.doi.org/10.1016/j.cell.2006.02.019.